Cholesterol: An important but relatively overemphasized risk factor for ischemic heart disease

Medical Hypotheses

Volumn 57, Issue 5, 2001, Pages 593-601

  Hellstrom, H R ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; FOLIC ACID; HOMOCYSTEINE; HYPOCHOLESTEROLEMIC AGENT; IRON; PYRIDOXINE;

ACUTE HEART INFARCTION; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BLOOD DONOR; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE SEVERITY; EMOTIONAL STRESS; ESTROGEN THERAPY; EXERCISE; FISH; HEALTH EDUCATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFECTION; INFLAMMATION; ISCHEMIC HEART DISEASE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SITTING; SMOKING; SMOKING CESSATION;

EID: 0035201063     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2001.1418     Document Type: Article

References (120)

1. On the statins, correcting plasma lipid levels, and preventing the clinical sequelae of atherosclerotic coronary heart disease
2. Heart attacks: Gone with the century?
3. Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease
4. Experimental cholesterol atherosclerosis and its relationship to human arteriosclerosis
5. Comparison of risk profiles for cardiovascular events: Implications for prevention
6. National cholesterol education program: Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
7. Cholesterol reduction yields clinical benefit: Impact of statin trials
8. Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials
9. A receptor-mediated pathway for cholesterol homeostasis
10. A new challenge for America: The national cholesterol education program
11. A survey of 246 suggested coronary risk factors
12. Prediction of coronary heart disease using risk factor categories
13. Primary prevention of coronary heart disease: Guidance from Framingham: A statement for healthcare professionals from the AHA task force on risk reduction
14. Task force on behavioral research in cardiovascular, lung, and blood health and disease
15. The altered homeostatic theory: A holistic approach to multiple diseases, including atherosclerosis, ischemic diseases, and hypertension
16. New evidence for the spasm of resistance vessel concept of ischemic diseases
17. Lack of association of infectious agents with risk of future myocardial infarction and stroke: Definitive evidence disproving the infection/coronary artery hypothesis?
18. Association of Helicobactor pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors
19. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
20. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease
21. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease
22. Chlamydia pneumoniae - Specific circulating immune complexes in patients with chronic coronary heart disease
23. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
24. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
25. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study
26. Dental disease and risk of coronary heart disease and mortality
27. Periodontal disease and cardiovascular disease
28. Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M
29. Is worry bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study
30. Living alone after myocardial infarction: Impact on prognosis
31. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample
32. Depression is a risk factor for coronary artery disease in men: The Precursors Study
33. A prospective study of anger and coronary heart disease: The Normative Aging Study
34. Components of hostility as predictors of sudden death and myocardial infarction in the Multiple Risk Factor Intervention Trial
35. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary heart disease
36. Symptoms of anxiety and the risk of coronary heart disease: The Normative Aging Study
37. In-hospital symptoms of psychological stress as predictors of long-term outcome after acute myocardial infarction in men
38. Triggering of acute myocardial infarction onset by episodes of anger
39. Sudden cardiac death triggered by an earthquake
40. Contributions of the Framingham study to the conquest artery disease
41. Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men: The Lipid Research Clinics Mortality Follow-up Study
42. A meta-analysis of physical activity in the prevention of coronary heart disease
43. Cigarette smoking, cardiovascular disease, and stroke: A statement for healthcare professionals from the American Heart Association
44. Cigarette smoking and coronary heart disease: Risks and management
45. Heart disease from passive smoking in the workplace
46. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) study
47. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
48. Plasma homocysteine levels and mortality in patients with coronary artery disease
49. Association between plasma homocysteine and coronary artery disease in older persons
50. Obesity is an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study
51. Medical hazards of obesity
52. Cigarette smoking, weight gain, and coronary mortality: Results from the Chicago Western Electric Study
53. Body weight, cardiovascular risk factors, and coronary mortality: 15-year follow-up of middle-aged men and women in eastern Finland
54. Insulin resistance implications for type II diabetes mellitus and coronary heart disease
55. The iron hypothesis-does iron cause atherosclerosis?
56. Association between body iron stores and the risk of acute myocardial infarction in men
57. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women
58. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: A prospective cohort study of men in eastern Finland
59. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
60. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
61. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
62. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
63. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S)
64. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
65. Effect of pravastatin on cardiovascular events in women after myocardial infarction: The Cholesterol and Recurrent Events (CARE) trial
66. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
67. Lipid-lowering interventions in angiographic trials
68. Vitamin E consumption and the risk of coronary heart disease in men
69. Vitamin E consumption and the risk of coronary disease in women
70. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The Established Populations for Epidemiologic Studies of the Elderly
71. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
72. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis
73. Vitamin E supplementation and cardiovascular events in high-risk patients
74. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina
75. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene
76. Alteration of type A behavior and reduction in cardiac recurrences in postmyocardial infarction patients
77. Psychologic treatment for the type A behavior pattern and for coronary heart disease: A meta-analysis of the literature
78. Effect of type A behavioral counseling on frequency of episodes of silent myocardial ischemia in coronary patients
79. The effect of a psychological intervention program on the risk of a new coronary event after angioplasty: A feasibility study
80. Unusually low incidence of death from myocardial infarction: Study of an Italian American community in Pennsylvania
81. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
82. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men
83. Physical exercise and reduced risk of nonfatal myocardial infarction
84. Leisure-time physical activity levels and risk of coronary heart disease and death: The Multiple Risk Factor Intervention Trial
85. Changes in physical fitness and all-cause mortality: A prospective study of healthy and unhealthy men
86. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men
87. Do physical activity and physical fitness avert premature mortality
88. 6 from diet and supplements in relation to risk of coronary heart disease among women
89. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
90. Final report on the aspirin component of the ongoing Physicians' Health Study
91. A prospective study of aspirin use and primary prevention of cardiovascular disease in women
92. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
93. Fish consumption and sudden cardiac death
94. Fish consumption and risk of sudden cardiac death
95. Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers: The Honolulu Heart Program
96. The inverse relation between fish consumption and 20-year mortality from coronary heart disease
97. Fish consumption and the 30-year risk of fatal myocardial infarction
98. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
99. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
100. Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease
101. β-blocker dosages and mortality after myocardial infarction: Data from a large health maintenance organization
102. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
103. Mediterranean alphalinolenic acid-rich diet in secondary prevention of coronary heart disease
104. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study
105. Donation of blood is associated with reduced risk of myocardial infarction: The Kuopio Ischaemic Heart Disease Risk Factor Study
106. Alcoholic beverages and myocardial infarction in young men
107. Type of alcoholic beverage and risk of myocardial infarction
108. Alcoholic beverages and myocardial infarction in young women
109. Prospective study of alcohol consumption and risk of coronary disease in men
110. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women
111. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians
112. Retardation of angiographic progression of coronary artery disease by nefedipine: Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT)
113. Can the progression of coronary sclerosis be influenced by calcium antagonists?
114. Arterial hypertension
115. Tobacco
116. Obesity
117. Physical activity
118. Electronic monitoring of compliance to lipid-lowering therapy in clinical practice